Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 12, 2015 08:31 ET | Source: iBio, Inc.

iBio Receives US and European Patents for Protein Expression Technology

NEWARK, DE--(Marketwired - Feb 12, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issuance of...
February 04, 2015 08:31 ET | Source: iBio, Inc.

iBio Adds to iBioModulator Portfolio and Product Pipeline

NEWARK, DE--(Marketwired - Feb 4, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of a new...
December 10, 2014 08:31 ET | Source: iBio, Inc.

iBio Provides Updates on Its IBIO-CFB03 Fibrosis Drug Candidate and Other Activities for the 2014 Annual Shareholders Meeting

NEWARK, DE--(Marketwired - Dec 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in biotechnology for developing and manufacturing plant-made pharmaceutical products, will provide shareholders and...
November 10, 2014 08:31 ET | Source: iBio, Inc.

iBio Grants Caliber License for Production of Antibodies Targeting Ebola

NEWARK, DE--(Marketwired - Nov 10, 2014) - iBio, Inc. (NYSE MKT: IBIO) and Caliber Biotherapeutics LLC executed an agreement, effective today, for an emergency use license to the iBioLaunch™...
October 22, 2014 08:31 ET | Source: iBio, Inc.

iBio Expands Exclusive Product Collaboration With Novici Biotech

NEWARK, DE--(Marketwired - Oct 22, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, and Novici Biotech LLC...
October 16, 2014 08:31 ET | Source: iBio, Inc.

iBio Responds to Inquiries About its Role in Emergency Response to Ebola Virus Disease Outbreak

NEWARK, DE--(Marketwired - Oct 16, 2014) - iBio, Inc. (NYSE MKT: IBIO) today confirmed, in response to shareholder and media inquiries: (i) the applicability of its issued U.S. iBioLaunch™...
October 03, 2014 17:00 ET | Source: iBio, Inc.

iBio Reports on Filing of 2014 Annual Report

NEWARK, DE--(Marketwired - Oct 3, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced, as required...
September 02, 2014 08:31 ET | Source: iBio, Inc.

Dr. Thomas A. Medsger Jr. Joins iBio Clinical Advisory Board

NEWARK, DE--(Marketwired - Sep 2, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of biotechnology for developing and manufacturing plant-made pharmaceutical products, has appointed Thomas...
August 28, 2014 08:31 ET | Source: iBio, Inc.

iBio Receives European Patent Allowances for Protein Expression Technology

NEWARK, DE--(Marketwired - Aug 28, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, received notices of intention to...
August 26, 2014 08:31 ET | Source: iBio, Inc.

iBio Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital

NEWARK, DE--(Marketwired - Aug 26, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, today announced it has...

Next Page keyboard_arrow_right